Journal of Clinical & Experimental OncologyISSN: 2324-9110

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Eva Karadi Balazs Kollar Author

Subjects of specialization
Mucoepidermoid carcinoma, Cancer chemotherapy, Prostate biomarker, Endometrial cancer, Tumor marker

Affiliation
Department of Hematology, Kaposi M

Biography

Eva Karadi Balazs Kollar was working in the Department of Hematology, Kaposi Mór Teaching Hospital, Kaposvár, Hungary. He has more than 40 publications. His current research area related to osteoarthropathy


Publications

Case Report Subscription

Is Metothrexate so Harmless in Patients with Autoimmune Disorders?

Author(s):

Adam Kellner, Vasana S Kellner, Eva Karadi Balazs Kollar and Miklos Egyed

The incidence of autoimmune diseases increasing nowdays. Despite of the development of diagnosis and management of diseases, they remained chronic diseases. The patient’s lifespan expansion requires long-term treatment with harmful agents, such as Metothrexate or other immunosuppressive drugs. The Metothrexate toxicities are based on the duration and cumulative dosing of drug, and the combination with other drugs. Myelosuppression and consequent pancytopenia is the most frequent hematologic toxicity, which occur mostly later during low dose Metothrexate administration. We demonstrate three cases of low dose metothrexate toxicity in older patients with rheumatoid arthritis and psoriasis. All patients were treated with low dose Metothrexate along more than one year continuously. Two... view moreĀ»

DOI: 10.4172/2324-9110.1000202

Abstract HTML PDF



Google Scholars / Researchers Sites

GET THE APP